NCI Treatmentಪರಿಶೀಲಿಸಿದ ಖಾತೆ

@NCItreatment

News and information from the official Twitter account of the NCI Division of Cancer Treatment & Diagnosis. Privacy

ಜನವರಿ 2016 ಸಮಯದಲ್ಲಿ ಸೇರಿದ್ದಾರೆ

ಟ್ವೀಟ್‌ಗಳು

ನೀವು @NCItreatment ಅವರನ್ನು ತಡೆಹಿಡಿದಿರುವಿರಿ

ಈ ಟ್ವೀಟ್‌ಗಳನ್ನು ವೀಕ್ಷಿಸಲು ನೀವು ಖಚಿತವಾಗಿ ಬಯಸುವಿರಾ? ಟ್ವೀಟ್ ವೀಕ್ಷಣೆಯು @NCItreatment ಅವರ ತಡೆತೆರವುಗೊಳಿಸುವುದಿಲ್ಲ

  1. ಪಿನ್ ಮಾಡಿದ ಟ್ವೀಟ್
    ನವೆಂ 2

    The Division of Cancer Treatment and Diagnosis provides research resources to the scientific community - , Software, Diagnostics, , Drug Discovery and Drug Development, . See how to access them here:

    ರದ್ದುಗೊಳಿಸು
  2. 1 ಗಂಟೆ ಹಿಂದೆ

    2018 Highlight from Division of Cancer Treatment and Diagnosis ---- NIH Convened a Conference on Cancer, Autoimmunity and Immunology. Learn about it here:

    ರದ್ದುಗೊಳಿಸು
  3. 6 ಗಂಟೆಗಳ ಹಿಂದೆ

    2018 Highlight from Division of Cancer Treatment and Diagnosis ---- The NCI Patient-Derived Models Repository released new patient-derived cell cultures and cancer-associated fibroblasts to the scientific community. Learn about it here:

    ರದ್ದುಗೊಳಿಸು
  4. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    22 ಗಂಟೆಗಳ ಹಿಂದೆ

    Truly saddened by the loss of Dr. Andrew Hruszkewycz. A highly respected member of the NCI family, he led the prostate & bladder portfolios of the Specialized Programs of Research Excellence. He was devoted to the work of facilitating a cure for cancer. He will be missed.

    ರದ್ದುಗೊಳಿಸು
  5. ಡಿಸೆಂ 19

    2018 Highlight from Division of Cancer Treatment and Diagnosis ---- launched Navigator, a resource for specimens and data from cancer clinical trials. Learn about it here:

    ರದ್ದುಗೊಳಿಸು
  6. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    ಡಿಸೆಂ 18

    In FY2019, we plan to increase support for research project grants, stay true to the vision of , & prioritize training. In my Cancer Currents blog post about the FY2019 budget, I explain how we’ll do it.

    ರದ್ದುಗೊಳಿಸು
  7. ಡಿಸೆಂ 18

    Read the last newsletter of the year from Division of Cancer Treatment and Diagnosis. See the latest DCTD cancer news and research all in one place, including a Spotlight on the Cancer Diagnosis Program with Dr. Lyndsay Harris. It's all here:

    ರದ್ದುಗೊಳಿಸು
  8. ಡಿಸೆಂ 17

    New Resource for the Scientific Community - - - Transcriptional Pharmacodynamics Workbench provides gene expression data for more than 12,000 genes in NCI-60 Human Tumor Cell Lines treated with 15 different anti-cancer agents + data analysis tools:

    ರದ್ದುಗೊಳಿಸು
  9. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    ಡಿಸೆಂ 14

    TCIA now hosts a large collection of ! Featured here: are pathology slides from a range of different from Proteomic Analysis Consortium () -

    ರದ್ದುಗೊಳಿಸು
  10. ಡಿಸೆಂ 14

    2018 Highlights from 's Specialized Programs of Research Excellence (SPOREs) --- collaborative, interdisciplinary, projects & 2018 publications from 8 organ sites:

    ರದ್ದುಗೊಳಿಸು
  11. ಡಿಸೆಂ 13

    Read the fall 2018 newsletter from Division of Cancer Treatment and Diagnosis. See the latest DCTD cancer news and research all in one place, including a tribute to Dr. Jeff Abrams on his recent retirement. Read it all here:

    ರದ್ದುಗೊಳಿಸು
  12. ಡಿಸೆಂ 12

    The Translational Research Program supports the Specialized Programs of Research Excellence (SPOREs). Read about the 2018 SPORE workshops on collaborative, interdisciplinary in specific organ sites:

    ರದ್ದುಗೊಳಿಸು
  13. ಡಿಸೆಂ 11

    Live videocast at 8:45 am Eastern today! Day 2 of Workshop on Cell-based for Solid Tumors. Hear about the state of preclinical and clinical development for cell-based immunotherapies for cancer. Agenda & videocast information:

    ರದ್ದುಗೊಳಿಸು
  14. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    ಡಿಸೆಂ 10

    We have some big changes in to announce next month. We will be expanding eligibility to more people with and opening new substudies! Stay tuned. And thanks to our partners

    ರದ್ದುಗೊಳಿಸು
  15. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    ಡಿಸೆಂ 10

    With the workshop on cell-based immunotherapy under way, here's our summary on types of :

    ರದ್ದುಗೊಳಿಸು
  16. ಡಿಸೆಂ 10

    Watch live videocast at 9:00 am Eastern today! Day 1 of Workshop on Cell-based for Solid Tumors. Agenda & videocast information: Hear about the state of preclinical and clinical development for cell-based immunotherapies for cancer.

    ರದ್ದುಗೊಳಿಸು
  17. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    ಡಿಸೆಂ 6

    You can watch NCI's workshop on cell-based immunotherapy for solid tumors next week. Details and link to videocast:

    ರದ್ದುಗೊಳಿಸು
  18. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    ಡಿಸೆಂ 6

    's is seeking to fill two Supervisory positions: - Associate Director (AD), Cancer Therapy Evaluation Program (CTEP) - Branch Chief, Immuno-Oncology Branch (IOB). Learn more and apply:

    ರದ್ದುಗೊಳಿಸು
  19. ಡಿಸೆಂ 6

    Learn about ’s Pediatric Early Phase Clinical Trials Network (PEP-CTN).

    ರದ್ದುಗೊಳಿಸು
  20. ಅವರು ಮರುಟ್ವೀಟಿಸಿದ್ದಾರೆ
    ಡಿಸೆಂ 4

    Ibrutinib + rituximab superior to standard treatment for some patients with CLL. Lead investigator Dr. Tait Shanafelt of discussed the practice-changing interim analysis of a clinical trial at . Read & 's press release:

    ಈ ಥ್ರೆಡ್ ತೋರಿಸಿ
    ರದ್ದುಗೊಳಿಸು
  21. ಡಿಸೆಂ 4

    New Resource for the Scientific Community - - - Transcriptional Pharmacodynamics Workbench provides gene expression data for more than 12,000 genes in NCI-60 Human Tumor Cell Lines treated with 15 different anti-cancer agents + data analysis tools:

    ರದ್ದುಗೊಳಿಸು

ಲೋಡಿಂಗ್ ಸಮಯ ಸ್ವಲ್ಪ ತೆಗೆದುಕೊಳ್ಳುತ್ತಿರುವಂತೆನಿಸುತ್ತದೆ.

Twitter ಸಾಮರ್ಥ್ಯ ಮೀರಿರಬಹುದು ಅಥವಾ ಕ್ಷಣಿಕವಾದ ತೊಂದರೆಯನ್ನು ಅನುಭವಿಸುತ್ತಿರಬಹುದು. ಮತ್ತೆ ಪ್ರಯತ್ನಿಸಿ ಅಥವಾ ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗೆ Twitter ಸ್ಥಿತಿಗೆ ಭೇಟಿ ನೀಡಿ.

    ಇದನ್ನೂ ಸಹ ನೀವು ಇಷ್ಟಪಡಬಹುದು

    ·